Skip to main content
HairCited

Minoxidil para Perda Capilar de Padrão Feminino

A

Baseado em 67 estudos (4 meta-analyses, 11 RCTs) com 28,815 participantes no total. 53/67 estudos mostram efeitos positivos.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Conclusão

Research strongly suggests that minoxidil may help women with female pattern hair loss regain hair density, supported by numerous high-quality clinical trials.

  • 67 studies including 11 RCTs and 4 meta-analyses specifically in women
  • 79% of studies report positive effects on hair growth
  • Low-dose oral minoxidil is emerging as a well-tolerated alternative to topical application
  • Combination with other ingredients like spironolactone may enhance results

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Efeito: None None

População: women with androgenetic alopecia (female pattern hair loss)

Other
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern …
Dose: MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day vs: None Outcome: consensus recommendations for managing pattern hair loss Efeito: None None

População: hair transplant patients with male and female pattern hair loss (Delphi panel consensus)

review
Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current …
Dose: varies by agent and study vs: Placebo Efeito: variable; oral antiandrogens demonstrate some efficacy; topical antiandrogens possibly fewer systemi None
narrative review
Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.
Dose: None vs: Placebo Efeito: None None
randomized controlled trial n=45 16 weeks Open-label
Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in …
Dose: Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi vs: Placebo Efeito: Groups A and C showed significant improvement on Sinclair scale and trichoscopic hair density; Group None
Review
Male and female pattern hair loss.
Dose: None vs: Placebo Efeito: None None

Key Statistics

111

Estudos

37800

Participantes

Positive

A

Nota

Referenced Papers

Australian prescriber 2025 2 citações
Annals of dermatology 2025
SAGE open medical … 2024 3 citações
Drugs 2023 221 citações
Anais brasileiros de … 2023 29 citações
Journal of cosmetic … 2023 3 citações
The Journal of … 2022 170 citações
Faculty reviews 2022 44 citações
Journal of cosmetic … 2022 7 citações
Journal of the … 2021 42 citações
American journal of … 2020 127 citações
International journal of … 2020 58 citações
Indian dermatology online … 2020 31 citações
Actas dermo-sifiliograficas 2019 5 citações
International journal of … 2018 129 citações
Australian journal of … 2018 8 citações
JAMA dermatology 2017 121 citações
The Cochrane database … 2016 18 citações
The Medical clinics … 2015 66 citações
World journal of … 2015 62 citações
Seminars in cutaneous … 2015 20 citações
Clinical obstetrics and … 2015 9 citações
Current problems in … 2015 8 citações
Skin therapy letter 2014 29 citações
Journal of drugs … 2014 26 citações
Dermatologic clinics 2013 78 citações
International journal of … 2013 61 citações
Indian journal of … 2013 16 citações
International journal of … 2013
The Cochrane database … 2012 15 citações
Skinmed 2012 5 citações
The Australasian journal … 2011 44 citações
Seminars in cutaneous … 2009 4 citações
American family physician 2009
Journal of the … 2008 290 citações
Clinical interventions in … 2007
Duodecim; laaketieteellinen aikakauskirja 2006
Journal of the … 2005 247 citações
The British journal … 2005 205 citações
The journal of … 2003 102 citações
Clinical and experimental … 2002 61 citações
Therapeutische Umschau. Revue … 2002 4 citações

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosagens Comumente Utilizadas

topical:
2-5% solution, twice daily

Limite superior: 5% topical solution

Dosagens Estudadas em Pesquisas

Dosagem Duração Efeito N
None -- Neutral --
MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day -- Positive --
varies by agent and study -- Positive --
None -- Positive --
Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi 16 weeks Positive 45
None -- Positive --
Spironolactone 100 mg once daily 24 weeks Positive 48
None -- Positive --

Melhor horário: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

Efeitos Colaterais Relatados

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

Interações Conhecidas

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

Ingestão máxima tolerável: 5% topical solution

Consulte sempre o seu profissional de saúde antes de iniciar qualquer suplemento.Sempre consulte seu profissional de saúde antes de iniciar qualquer suplemento.

Frequently Asked Questions

Does Minoxidil help with Perda Capilar de Padrão Feminino?
Based on 111 studies with 37,800 participants, there is strong evidence from multiple clinical trials that Minoxidil may support Perda Capilar de Padrão Feminino management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for Perda Capilar de Padrão Feminino?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and Perda Capilar de Padrão Feminino?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 111 peer-reviewed studies with 37,800 total participants. The overall direction of effect is positive.

Related Evidence

Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.